ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,210Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 225

$1.96M Total Retail Price of All Prescriptions

Rank: 3 out of 225

771 Patients Receiving at Least One Drug in Part D
14%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 771 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

13% of this provider’s 1,759 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$129 was the average price of a prescription from this provider, compared to $117 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
RISPERIDONE 946 104 1 3
FLUOXETINE HCL 709 61 2 7
BENZTROPINE MESYLATE 689 69 R 3 8
TRAZODONE HCL 678 102 4 1
SERTRALINE HCL 651 99 5 6
CITALOPRAM HBR 585 82 6 2
LAMOTRIGINE 567 66 7 9
VENLAFAXINE HCL ER 563 72 8 13
OLANZAPINE 516 109 9 14
DIVALPROEX SODIUM ER 505 41 10 18
QUETIAPINE FUMARATE 493 50 11 5
LITHIUM CARBONATE 474 64 12 16
BUPROPION XL 446 24 13 21
ABILIFY 401 23 14 12
ESCITALOPRAM OXALATE 369 46 15 25
BUSPIRONE HCL 362 78 16 19
PAROXETINE HCL 329 50 17 15
ZOLPIDEM TARTRATE 325 33 18 4
HALOPERIDOL 307 16 19 24
CYMBALTA 298 27 20 10
MIRTAZAPINE 273 27 21 11
HYDROXYZINE PAMOATE 252 27 R 22 28
TRIHEXYPHENIDYL HCL 250 38 R 23 52
SEROQUEL 247 15 24 22
HYDROXYZINE HCL 215 27 R 25 33
OXCARBAZEPINE 207 11 26 31
ZIPRASIDONE HCL 199 12 27 27
SEROQUEL XR 170 12 28 26
GABAPENTIN 168 0 29 17
DIVALPROEX SODIUM 162 19 30 23
INVEGA 122 0 31 50
CLOZAPINE 116 0 32 32
AMITRIPTYLINE HCL 115 24 R 33 34
GEODON 113 0 34 48
LEXAPRO 104 14 35 58
FLUVOXAMINE MALEATE 102 0 36 61
BUPROPION HCL SR 102 21 36 20
AMPHETAMINE SALT COMBO 98 0 S2 38 29
TOPIRAMATE 97 0 39 37
PROPRANOLOL HCL 93 0 40 45
ZYPREXA 90 18 41 56
PERPHENAZINE 81 0 42 40
HALOPERIDOL DECANOATE 80 12 43 42
RISPERDAL CONSTA 80 13 43 43
METHYLPHENIDATE HCL 79 0 45 54
PRISTIQ ER 75 20 46 36
CLOMIPRAMINE HCL 71 14 R 47 68
INVEGA SUSTENNA 69 0 48 44
CARBAMAZEPINE 68 0 49 39
LUNESTA 67 18 50 47
LOXAPINE 66 0 51 60
DOXEPIN HCL 58 0 52 38
THIOTHIXENE 56 25 53 62
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.